Nunzia Pharmaceutical Company (NUNZ)

NUNZ Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-96.99	-78.06	-101.02	-0.03	-0.02	-0.01
Stock-Based Compensation	96.75	78	0	-	-	-
Other Operating Activities	0	-	100.98	-	-0.01	-
Change in Accounts Payable	0.03	-0.02	0	0.01	0	0.01
Change in Other Net Operating Assets	0	-	-	0.02	0.03	0
Operating Cash Flow	-0.2	-0.09	-0.03	-0	-	-
Short-Term Debt Issued	-	0.09	0.01	-	-	-
Long-Term Debt Issued	-	-	0.02	-	-	-
Total Debt Issued	0.1	0.09	0.03	-	-	-
Net Debt Issued (Repaid)	0.1	0.09	0.03	-	-	-
Issuance of Common Stock	0.14	-	-	0	-	-
Financing Cash Flow	0.23	0.09	0.03	0	-	-
Net Cash Flow	0.03	0	-	-	-	-
Levered Free Cash Flow	36.09	-	-	-	-	-
Unlevered Free Cash Flow	36.09	-	-	-	-	-
Change in Working Capital	0.04	-0.02	0	0.03	0.03	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.